NasdaqGM - Nasdaq Real Time Price USD
Clearside Biomedical, Inc. (CLSD)
At close: November 5 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,111.0000
-18,135.0000
-13,365.0000
-10,733.0000
-13,120.0000
Investing Cash Flow
-12,059.0000
-1,777.0000
-246.0000
--
-55.0000
Financing Cash Flow
14,403.0000
414.0000
31,333.0000
23,782.0000
7,867.0000
End Cash Position
18,238.0000
28,920.0000
48,418.0000
30,696.0000
17,647.0000
Interest Paid Supplemental Data
--
--
--
--
524.0000
Capital Expenditure
-1,045.0000
-1,777.0000
-246.0000
--
-55.0000
Issuance of Capital Stock
15,319.0000
1,666.0000
566.0000
23,283.0000
11,958.0000
Issuance of Debt
--
--
--
--
991.0000
Repayment of Debt
--
--
--
--
-5,340.0000
Free Cash Flow
-20,156.0000
-19,912.0000
-13,611.0000
-10,733.0000
-13,175.0000
12/31/2020 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGNX REGENXBIO Inc.
8.92
+1.83%
OCUL Ocular Therapeutix, Inc.
10.57
+2.92%
AURA Aura Biosciences, Inc.
10.29
+1.18%
EYPT EyePoint Pharmaceuticals, Inc.
11.61
-0.77%
CTMX CytomX Therapeutics, Inc.
0.9930
-1.68%
LPTX Leap Therapeutics, Inc.
3.5500
-3.27%
QURE uniQure N.V.
6.06
+8.99%
LCTX Lineage Cell Therapeutics, Inc.
0.8445
+0.70%
IRD Opus Genetics, Inc.
1.1650
-0.43%
OTLK Outlook Therapeutics, Inc.
6.35
+4.79%